SY-009

· Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SY-009, covering 2022-06-21 to 2022-06-21. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of Different Doses of SY-009 in Patients With Type 2 Diabetes Mellitus [Phase 2]